Non-native beta-sheet formation: insights into protein amyloidosis
Chinlin Guo, Herbert Levine, and David A. Kessler

TL;DR
This paper presents a theoretical framework explaining how sequence-independent beta-sheet aggregation occurs in protein amyloidosis, highlighting the role of inter-sheet stacking and predicting critical polymer lengths relevant to disease.
Contribution
It introduces a novel theoretical model linking hydrogen-bond cooperativity to in vivo beta-sheet aggregation and disease-related polymer length thresholds.
Findings
Aggregation driven by inter-sheet stacking dynamics
Prediction of minimal polymer length for aggregation
Correlation with critical lengths in poly-glutamine diseases
Abstract
Protein amyloidosis is a cytopathological process characterized by the formation of highly beta-sheet-rich fibrils. How this process occurs and how to prevent/treat the associated diseases are not completely understood. Here, we carry out a theoretical investigation of sequence-independent beta-sheet formation, based on recent findings regarding the cooperativity of hydrogen-bond network formation. Our results strongly suggest that in vivo beta-sheet aggregation is induced by inter-sheet stacking dynamics. This leads to a prediction for the minimal length of susceptible polymer needed to form such an aggregate. Remarkably, the prediction corresponds quite well with the critical lengths detected in poly-glutamine-related diseases. Our work therefore provides a theoretical framework capable of understanding the underlying mechanism and shedding light on therapy strategies of protein…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMicrobial metabolism and enzyme function · Amyloidosis: Diagnosis, Treatment, Outcomes · Alzheimer's disease research and treatments
